Cargando…

Blood biomarkers with Parkinson's disease clusters and prognosis: The oxford discovery cohort

BACKGROUND: Predicting prognosis in Parkinson's disease (PD) has important implications for individual prognostication and clinical trials design and targeting novel treatments. Blood biomarkers could help in this endeavor. METHODS: We identified 4 blood biomarkers that might predict prognosis:...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lawton, Michael, Baig, Fahd, Toulson, Greg, Morovat, Alireza, Evetts, Samuel G., Ben‐Shlomo, Yoav, Hu, Michele T.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons, Inc. 2019
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7028059/ https://www.ncbi.nlm.nih.gov/pubmed/31693246 http://dx.doi.org/10.1002/mds.27888

Ejemplares similares

Parkinson’s Disease Subtypes in the Oxford Parkinson Disease Centre (OPDC) Discovery Cohort
por: Lawton, Michael, et al.
Publicado: (2015)

Genetics of validated Parkinson’s disease subtypes in the Oxford Discovery and Tracking Parkinson’s cohorts
por: Lawton, Michael, et al.
Publicado: (2022)

Delineating nonmotor symptoms in early Parkinson's disease and first‐degree relatives
por: Baig, Fahd, et al.
Publicado: (2015)

Statins are underused in recent-onset Parkinson's disease with increased vascular risk: findings from the UK Tracking Parkinson's and Oxford Parkinson's Disease Centre (OPDC) discovery cohorts
por: Swallow, Diane M A, et al.
Publicado: (2016)

Cohort profile: the Oxford Parkinson’s Disease Centre Discovery Cohort MRI substudy (OPDC-MRI)
por: Griffanti, Ludovica, et al.
Publicado: (2020)

Prodromal Parkinsonism and Neurodegenerative Risk Stratification in REM Sleep Behavior Disorder
por: Barber, Thomas R, et al.
Publicado: (2017)

Identification of a possible proteomic biomarker in Parkinson’s disease: discovery and replication in blood, brain and cerebrospinal fluid
por: Winchester, Laura, et al.
Publicado: (2022)

Personality and addictive behaviours in early Parkinson's disease and REM sleep behaviour disorder
por: Baig, Fahd, et al.
Publicado: (2017)

Predictors of motor complications in early Parkinson's disease: A prospective cohort study
por: Kelly, Mark J., et al.
Publicado: (2019)

Impulse control disorders in Parkinson disease and RBD: A longitudinal study of severity
por: Baig, Fahd, et al.
Publicado: (2019)

Predicting motor, cognitive & functional impairment in Parkinson's
por: Lo, Christine, et al.
Publicado: (2019)

Commentary: “Association between diabetes mellitus, prediabetes and risk, disease progression of Parkinson's disease: a systematic review and meta-analysis”
por: Lawton, Michael, et al.
Publicado: (2023)

Mitochondrial dysfunction and increased glycolysis in prodromal and early Parkinson's blood cells
por: Smith, Amy M., et al.
Publicado: (2018)

Developing and validating Parkinson’s disease subtypes and their motor and cognitive progression
por: Lawton, Michael, et al.
Publicado: (2018)

A composite clinical motor score as a comprehensive and sensitive outcome measure for Parkinson’s disease
por: Lo, Christine, et al.
Publicado: (2022)

The Oxford handbook of the Russian economy
por: Weber, Shlomo, et al.
Publicado: (2013)

Equating scores of the University of Pennsylvania Smell Identification Test and Sniffin' Sticks test in patients with Parkinson's disease
por: Lawton, Michael, et al.
Publicado: (2016)

Testing Shortened Versions of Smell Tests to Screen for Hyposmia in Parkinson's Disease
por: Auger, Stephen D., et al.
Publicado: (2020)

Combining biomarkers for prognostic modelling of Parkinson’s disease
por: Vijiaratnam, Nirosen, et al.
Publicado: (2022)

Comparison between four published definitions of hyposmia in Parkinson's disease
por: Kanavou, Sofia, et al.
Publicado: (2021)

Inflammation biomarker discovery in Parkinson’s disease and atypical parkinsonisms
por: Santaella, Anna, et al.
Publicado: (2020)

Striatal Dopamine Loss in Early Parkinson's Disease: Systematic Review and Novel Analysis of Dopamine Transporter Imaging
por: Heng, Nicholas, et al.
Publicado: (2023)

Universal clinical Parkinson’s disease axes identify a major influence of neuroinflammation
por: Sandor, Cynthia, et al.
Publicado: (2022)

Diabetes and Neuroaxonal Damage in Parkinson's Disease
por: Vijiaratnam, Nirosen, et al.
Publicado: (2022)

The Impact of Type 2 Diabetes in Parkinson's Disease
por: Athauda, Dilan, et al.
Publicado: (2022)

Genome-wide Analysis of Motor Progression in Parkinson Disease
por: Martínez Carrasco, Alejandro, et al.
Publicado: (2023)

Oxford using computing clusters to solve universal antimatter mystery
por: Cushing, Karl
Publicado: (2003)

A diagnostic test accuracy study investigating GP clinical impression and brief cognitive assessments for dementia in primary care, compared to specialised assessment
por: Creavin, Samuel Thomas, et al.
Publicado: (2023)

A detailed clinical study of pain in 1957 participants with early/moderate Parkinson's disease
por: Silverdale, Monty A., et al.
Publicado: (2018)

Targeted Discovery and Validation of Plasma Biomarkers of Parkinson’s Disease
por: Pan, Catherine, et al.
Publicado: (2014)

Discovery of Volatile Biomarkers of Parkinson’s Disease from Sebum
por: Trivedi, Drupad K., et al.
Publicado: (2019)

Features of GBA-associated Parkinson’s disease at presentation in the UK Tracking Parkinson’s study
por: Malek, Naveed, et al.
Publicado: (2018)

The Association Between Frailty and Parkinson’s Disease in the ReSPOnD Trial
por: Smith, Natalie, et al.
Publicado: (2021)

Genetic meta-analysis of levodopa induced dyskinesia in Parkinson’s disease
por: Martinez-Carrasco, Alejandro, et al.
Publicado: (2023)

Genetic meta-analysis of levodopa induced dyskinesia in Parkinson’s disease
por: Martinez-Carrasco, Alejandro, et al.
Publicado: (2023)

The Oxford history of the american people
por: Morison, Samuel Eliot, 1887-1976
Publicado: (1972)

Analysis of change in patient-reported outcome measures with floor and ceiling effects using the multilevel Tobit model: a simulation study and an example from a National Joint Register using body mass index and the Oxford Hip Score
por: Sayers, Adrian, et al.
Publicado: (2020)

REM sleep behaviour disorder is associated with worse quality of life and other non-motor features in early Parkinson's disease
por: Rolinski, Michal, et al.
Publicado: (2014)

Discovery and verification of panels of T-lymphocyte proteins as biomarkers of Parkinson's disease
por: Alberio, Tiziana, et al.
Publicado: (2012)

Determinants of coping styles of people with Parkinson’s Disease
por: Prins, Eva M., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_e4ou7go7umg83fdi94nbm5p8nh